NOT-AI-04-048: ADDENDUM TO RFA-AI-04-001

Department of Health
and Human Services (HHS)

NIH... Turning Discovery Into Health^®

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.

ADDENDUM TO RFA-AI-04-001 RELEASE DATE: July 27, 2004 NOTICE: NOT-AI-04-048 EXPIRATION DATE: June 9, 2005, unless reissued National Institute of Allergy and Infectious Diseases (NIAID) (http://www.niaid.nih.gov) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (http://www.niams.nih.gov/) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (http://www.niddk.nih.gov/) National Institute of Neurological Disorders and Stroke (NINDS) (http://www.ninds.nih.gov/) LETTER OF INTENT RECEIPT DATES: One month prior to application receipt date. APPLICATION RECEIPT DATES: Applications will be accepted MONTHLY on the 9th of each month. The last receipt date will be June 9, 2005. National Institute of Allergy and Infectious Diseases (NIAID) is amending RFA-AI-04-001 Hyperaccelerated Award/Mechanisms In Immunomodulation Trials (http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-04-001.html) to change the following: 1) amend the participating institutes to include those listed above; 2) provide NIAMS program staff contact information under Where to Send Inquiries, below; and 2) revise funds available and number of anticipated awards for FY2005. The participating Institutes intend to commit approximately $1,500,000 in FY 2005 to fund 4 to 5 new grants for immune mechanistic, ancillary studies of immunomodulatory interventions for immune system mediated diseases clinical trials and of vaccine clinical trials for non-HIV/AIDS infectious diseases. NIAID does not have specified funds committed in FY 2005 as were available in FY 2004 for immune mechanistic ancillary studies of vaccine clinical trials for the prevention and treatment NIAID Category A, B and C agents of bioterrorism and non-HIV/AIDS emerging/re-emerging infectious diseases; however, these applications are responsive to this RFA. WHERE TO SEND INQUIRIES We encourage inquiries concerning this RFA and welcome the opportunity to answer questions from potential applicants. Inquiries may fall into three areas: scientific/research, peer review, and financial or grants management issues: o Direct questions about scientific/research issues to: Annette Rothermel, Ph.D. Division of Allergy, Immunology and Transplantation National Institute of Allergy and Infectious Diseases Room 3020, MSC-6601 6610 Rockledge Drive Bethesda, MD 20892-6601 Telephone: (301) 496-7104 FAX: (301) 480-1450 Email: ar299e@nih.gov Susana A. Serrate-Sztein, M.D. Rheumatic Diseases Program National Institute of Arthritis and Musculoskeletal and Skin Diseases Room 5AS-25E, MSC-6500 45 Center Drive Bethesda, MD 20892-6500 Telephone: 301-594-5032 FAX: 301-480-4543 Email: ss86e@nih.gov Beena Akolkar, Ph.D. Division of Diabetes, Endocrinology, and Metabolic Diseases National Institute of Diabetes and Digestive and Kidney Diseases Room 681 6707 Democracy Boulevard Bethesda, MD 20892 Telephone: 301-594-8812 FAX: 301-480-3503 Email: ba92i@nih.gov Ursula Utz, Ph.D. National Institute of Neurological Disorders and Stroke Room 234, MSC-2134 6001 Executive Boulevard Bethesda, MD 20892-2134 Telephone: 301-496-1431 FAX: 301-480-2424 Email: uu1p@nih.gov o Direct questions about peer review issues to: Samuel C. Edwards, Ph.D. Immunology Initial Review Group Center for Scientific Review Room 4200, MSC-7812 6701 Rockledge Drive Bethesda, MD 20892-7812 (overnight carrier - FEDEX, UPS, Airborne, etc.) 20817 Telephone: 301-435-1152 FAX: 301-480-4042 Email: se83s@nih.gov o Direct questions about financial or grants management matters to: Ann White-Devine Division of Extramural Activities National Institute of Allergy and Infectious Diseases Room 2118, MSC-7614 6700-B Rockledge Drive Bethesda, MD 20892-7614 Phone: 301-402-5601 FAX: 301-480-3780 e-mail: ad22x@nih.gov

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices